SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Trudeau who wrote (161)	1/13/2002 9:46:59 PM
From: Jim Oravetz	Read Replies (2) of 164

"Full Phase I results, which showed some form of tumor response in six out of 12 patients and no adverse events,"snip... Any drug in PI still has lots of things to prove. The further along the trials are the more likely that they will work ok. Remember that only about 10% of drugs get through to the approval phase. 12 patients is a small sampling of the general population to base the likely success of this drug. PII will move to 40 people or more, but this is still a small population to work with. Lots can go wrong here as well. Look at IMCL, a much bigger biotech, that seems to have stumbled badly with the trial design and the way they presented the data to the FDA. The stock has taken a big hit since, worst case, a new trial may be needed. Biotech is very tricky with picking winners this early. I can not comment on ONC specifically, since I have not followed the science. Use your judgment and spread things around in the bio field. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next